Kolexia
Zoulim Fabien
Gastro-entérologie
Hôpital La Croix-Rousse
Lyon, France
544 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Hépatite Hépatite B Hépatite B chronique Hépatite chronique Hépatite C Cirrhose du foie Carcinome hépatocellulaire Hépatite C chronique Tumeurs du foie

Industries

Gilead
23 collaboration(s)
Dernière en 2023
GSK
14 collaboration(s)
Dernière en 2023
Roche
3 collaboration(s)
Dernière en 2020
Janssen
3 collaboration(s)
Dernière en 2022

Dernières activités

RES-HBV: Evaluation of the Intrahepatic Hepatitis B Virus Reservoir and Its Immunological Characteristics in Chronically HBV-infected Patients - Pilot Study
Essai Clinique (Hospices Civils de Lyon)   12 mars 2024
B-Well 2: Phase 3 Multicenter, Randomized, Double-Blind, Study to Assess the Efficacy and Safety of Treatment With Bepirovirsen in Nucleos(t)Ide Analogue-treated Participants With Chronic Hepatitis B Virus (B-Well 2)
Essai Clinique (GSK)   29 février 2024
Dataids_PEC: Dataids Prospective Observational Cohort on Quality of Care of French HIV Infected Patients
Essai Clinique (DatAids)   26 février 2024
Virological and clinical outcomes of patients with HDV-related compensated cirrhosis treated with Bulevirtide monotherapy for 96 weeks: a retrospective multicenter european study (SAVE-D)
Abstracts of the 56th A.I.S.F. - Italian Association for theStudy of the Liver - Annual Meeting 2024Rome, March 14th -15th, 2024   01 février 2024
Bulevirtide monotherapy prevents liver decompensation and reduces mortality in patients with HDV-related cirrhosis: a case control study with propensity score weighted analysis
Abstracts of the 56th A.I.S.F. - Italian Association for theStudy of the Liver - Annual Meeting 2024Rome, March 14th -15th, 2024   01 février 2024
Replication-driven HBV cccDNA loss in chimeric mice with humanized livers.
bioRxiv : the preprint server for biology   28 décembre 2023
Cytosine base editing inhibits hepatitis B virus replication and reduces HBsAg expression and .
Molecular therapy. Nucleic acids   27 décembre 2023
Hepatitis C virus cure from direct-acting antivirals and mortality: Are people with and without a history of injection drug use in the same boat? (ANRS CO22 Hepather cohort).
Drug and alcohol review   22 décembre 2023
G-quadruplexes control hepatitis B virus replication by promoting cccDNA transcription and phase separation in hepatocytes.
Nucleic acids research   19 décembre 2023
Durability of Response After DAA Therapies - Fabien Zoulim, MD, PhD
Youtube @ Academic Medical Education   28 novembre 2023